E Fund Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
E Fund Management's TWST Position: Q2 2026 in Review
E Fund Management reduced its Twist Bioscience (TWST) stake by 53% in Q2 2026, selling an estimated $414K and leaving 5,744 shares worth $591K. The position accounts for 0.01% of the portfolio, ranked #236.
E Fund Management first reported a position in TWST in Q1 2022 and has held it in 16 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- E Fund Management held 5,744 shares of Twist Bioscience worth $591K as of Q2 2026.
- E Fund Management sold 6,356 Twist Bioscience shares in Q2 2026, an estimated $414K.
- Twist Bioscience made up 0.01% of E Fund Management's portfolio in Q2 2026, its #236 holding.
- E Fund Management first reported a position in Twist Bioscience in Q1 2022 and has held it in 16 quarters since.
- 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.